01 November 2025
: Case report 
Post-COVID-19-Associated Asymptomatic Sarcoidosis with Hypercalcemia and Renal Dysfunction: A Case Report and Literature Review
Challenging differential diagnosis, Rare disease, Rare coexistence of disease or pathology
Mrudula Thiriveedi
ABDEF 1*, Hersh Patel DF 2, Caitlin Curran BEF 2, Siddharth Patel DEF 1, Sujatha Baddam DEF 3, Rafik ElBeblawy DEF 1, Punuru J. Reddy ADE 1
DOI: 10.12659/AJCR.950045
Am J Case Rep 2025; 26:e950045
Table 3 Other reported cases of post-COVID-19 sarcoidosis.
| Authors | Age/sex | Interval between COVID-19 and sarcoidosis diagnosis | Sarcoidosis presentation | Diagnostics | Treatment and outcome |
|---|---|---|---|---|---|
| Somboonviboon et al []9 | 35 M | 10 weeks | Pulmonary and ocular | Imaging + biopsy | Prednisone with improvement |
| Capaccione et al []10 | 61 M | 14 months | Pulmonary | Imaging + biopsy | Prednisone with improvement |
| Subedi et al []11 | 26 M | 3 months | Pulmonary | Biopsy | Prednisone with improvement |
| Racil et al []12 | 41 F | 6 months | Pulmonary | Imaging + biopsy | Prednisone with improvement |
| Rodriguez-Nava et al []4 | 35 M | 24 months | Pulmonary and systemic symptoms | Biopsy | Prednisone with improvement |
| Mihalov et al []13 | 30 M | 3 weeks | Löfgren syndrome | Biopsy | Prednisone with improvement |
| Palones et al []14 | 45 F | 14 days | Cutaneous; pulmonary | Imaging + biopsy | Inhaled corticosteroids with improvement |
| Rodrigues et al []15 | 57 F | 20 days | Cutaneous; pulmonary | Imaging + biopsy | Prednisone and azathioprine with improvement |
| Rabufetti et al []16 | 31 M | 6 months | Cutaneous; Pulmonary | Imaging + biopsy | Prednisone with improvement |